U.S. Residential REITs Stock News

Leggett & Platt, Incorporated has reported past first-quarter 2026 results showing sales of US$918.2 million, down from US$1,022.1 million a year earlier, with net income falling from US$30.6 million to US$20 million. The simultaneous decline in both revenue and profitability gives investors a fresh data point on how the company is managing current demand conditions and cost pressures. We’ll now examine how this quarter’s weaker sales and earnings reshape Leggett & Platt’s investment...

Recent share performance and business profile Novo Nordisk (NYSE:NVO) has drawn investor attention after a mixed stretch for the stock, with the share price down 12.6% year to date yet up 16.5% over the past month. The Denmark based pharmaceutical group reports US$327.8b in revenue and US$121.96b in net income, primarily from its Diabetes and Obesity Care segment, alongside a smaller Rare Disease business. See our latest analysis for Novo Nordisk. At a share price of US$45.80, Novo Nordisk...

Nebius Group (NasdaqGS:NBIS) has opened 2026 with Q1 revenue of US$399 million and Basic EPS of US$2.40, alongside net income of US$621.2 million, setting a clear marker after a volatile run of prior quarters. The company has seen revenue move from US$55.3 million in Q1 2025 and US$35.2 million in Q4 2024 to US$399 million in Q1 2026, with Basic EPS shifting from a loss of US$0.48 in Q1 2025 and a loss of US$0.58 in Q4 2024 to a profit of US$2.40. This puts the focus firmly on how sustainable...

Cooper Companies (NasdaqGS:COO) has appointed Paul Keel to its Board of Directors. Keel will also serve on the Board’s Audit Committee. The appointment brings experience from senior executive roles at major medical technology and industrial companies. For investors watching Cooper Companies at a share price of $60.38, this board change comes after a period of weak stock performance. The stock is down 15.7% over the past 30 days, 25.6% year to date, and 25.9% over the past year, with a 37.9%...

SS Innovations International (NasdaqCM:SSII) opened 2026 with Q1 revenue of about US$11.1 million and a basic EPS loss of US$0.02, while trailing 12 month figures show revenue of roughly US$48.5 million and a basic EPS loss of US$0.05. Over the past reported quarters, revenue has ranged from about US$5.1 million in Q1 2025 to US$14.5 million in Q4 2025, with basic EPS losses moving between roughly US$0.00 and US$0.03 per share. Investors are therefore likely to focus on how efficiently that...

YETI Holdings (YETI) opened 2026 with Q1 revenue of US$380.4 million and basic EPS of US$0.13, alongside trailing twelve month revenue of US$1.9 billion and EPS of US$2.01 that frame the latest quarter against a fuller earnings picture. Over recent quarters the company has seen revenue move from US$351.1 million and EPS of US$0.20 in Q1 2025 through US$583.7 million and EPS of US$0.76 in Q4 2025, setting a clear baseline for how this new print fits into the broader trend. With trailing net...

Escalating conflict in the Middle East, including closures around the Strait of Hormuz and issues at Iran’s Kharg Island terminal, has pushed oil prices higher and put Exxon Mobil (XOM) firmly back in focus for investors. See our latest analysis for Exxon Mobil. At a share price of US$152.78, Exxon Mobil has logged a 24.57% year to date share price return. Its 1 year total shareholder return of 45.19% and 5 year total shareholder return of 212.06% point to strong longer term compounding...

Biohaven Ltd. reported first-quarter 2026 results in the past, narrowing its net loss to US$130.53 million from US$221.68 million a year earlier, while loss per share from continuing operations declined to US$0.88 from US$2.17. On the same day, Biohaven filed an omnibus shelf registration covering a wide range of securities, potentially giving the company considerable flexibility in how it may access capital in the future. With these earnings and the broad shelf registration in mind, we’ll...

In May 2026, Valpak Intelligence announced that its New Mover and New Business audience segments became directly available in LiveRamp’s Data Marketplace, giving marketers, brands, and agencies streamlined access to its postal-anchored identity data across major DSPs, SSPs, CTV platforms, and CRM destinations without separate licensing agreements. This partnership brings Valpak’s decades-built household identity spine, spanning approximately 135 million households and hundreds of millions of...

vTv Therapeutics (VTVT) opened Q1 2026 with reported revenue of US$36.8 million and basic EPS of US$1.94, putting a spotlight on the shift in its income statement after a series of quarterly losses. Over the past year, the company has seen quarterly revenue move from effectively US$0 in early 2025 to US$36.8 million in Q1 2026, while basic EPS has swung from a loss of US$0.77 in Q1 2025 to a profit of US$1.94, indicating a sharp change in how much of each sales dollar is landing on the bottom...

Keros Therapeutics (KROS) has just posted Q1 2026 results, with revenue of US$0.4 million, a basic EPS loss of US$1.21 and a net loss of US$23.7 million, setting the tone for the quarter at a share price of US$10.99. The company has seen quarterly revenue move from US$211.2 million in Q1 2025 to US$0.4 million in Q1 2026, while basic EPS shifted from a profit of US$3.66 to a loss of US$1.21. This puts the spotlight on how changes in revenue expectations and potential margin developments could...

In early May 2026, Vertex Pharmaceuticals filed a new US$2.87 billion shelf registration for 6,400,000 common shares tied to its employee stock ownership plan after closing several earlier ESOP-related shelf programs, alongside reporting first-quarter 2026 revenue of US$2,986.9 million and net income of US$1,031.4 million. At the same time, Vertex expanded access for its one-time CRISPR/Cas9 therapy CASGEVY through a reimbursement agreement with Germany’s GKV-Spitzenverband and reaffirmed...

Robotaxi expansion puts DiDi Global (DIDI.Y) in focus DiDi Global (DIDI.Y) is drawing attention after moving faster on autonomous driving, securing a road test license in Beijing for its latest robotaxi and preparing pilot programs in the UAE. See our latest analysis for DiDi Global. Despite the robotaxi progress, recent momentum has been weak. The share price is US$3.58 with a year to date share price return down 35.61%, while the 3 year total shareholder return is 12.23%, hinting at a mixed...

Rapid Micro Biosystems (RPID) opened Q1 2026 with revenue of US$8.0 million and a basic EPS loss of US$0.31, while trailing twelve month revenue stood at US$34.4 million alongside a TTM basic EPS loss of US$1.11. Over recent quarters the company has seen revenue move between US$7.2 million and US$11.3 million, with quarterly basic EPS losses ranging from US$0.22 to US$0.31. This latest print keeps the focus squarely on how fast margins can tighten and losses can narrow from here. See our full...

In recent days, Texas Instruments reported better-than-expected first-quarter results, highlighting strong analog revenue growth powered by industrial demand and a sharp rise in AI data center-related sales, while sector-wide optimism around semiconductors has been reinforced by broader index gains and supportive earnings across many chipmakers. At the same time, management’s emphasis on analog and embedded processing strengths, expanding internal manufacturing capacity, and upcoming...

Versant Media Group (VSNT) opened Q1 2026 with revenue of US$1.7 billion and basic EPS of US$1.99, setting the tone for how investors will weigh the latest move in profitability. Over recent periods the company has seen quarterly revenue move from US$1.7 billion in Q1 2025 to US$1.6 billion in Q4 2025 and then to US$1.7 billion in Q1 2026, while net income excluding extra items shifted from US$334.5 million to US$181 million and then to US$286 million, giving a clear read on how earnings...

Earlier this week, STERIS plc reported its fourth-quarter and fiscal 2026 results, with full-year sales of US$5,935.9 million and net income of US$782.3 million, alongside new fiscal 2027 guidance calling for 7%–8% reported revenue growth and a fresh US$1.00 billion share repurchase authorization. Management paired record annual revenue and earnings per share with plans for substantial buybacks and elevated capital spending, signaling confidence in the durability of demand for its infection...

Kulicke and Soffa Industries recently reported fiscal second-quarter 2026 results, with sales rising to US$242.62 million and net income improving to US$35.15 million, a shift from a net loss a year earlier. Alongside the earnings rebound, the company outlined plans to increase capital spending to expand thermo-compression bonding capacity for advanced packaging used in AI and high-performance chips. We’ll now examine how this earnings improvement and stepped-up thermo-compression investment...

Wolverine World Wide (WWW) opened Q1 2026 with revenue of US$457.6 million and basic EPS of US$0.25, against a current share price of US$15.22. This sets a clear marker for how its latest quarter feeds into a steadily building earnings profile. The company has seen quarterly revenue move from US$412.3 million and EPS of US$0.13 in Q1 2025 to US$457.6 million and EPS of US$0.25 in Q1 2026. Trailing twelve month EPS stands at US$1.24 on revenue of roughly US$1.9 billion, giving investors a...

Why Ameriprise Financial (AMP) is back in focus Ameriprise Financial (AMP) is drawing fresh attention after Q1 2026 earnings highlighted revenue growth, firm operating margins, and a 12% year-over-year rise in assets under management to US$1.7b. See our latest analysis for Ameriprise Financial. The Q1 earnings beat and rising interest from investors like Gator Capital have helped the stock regain some traction, with a 2.9% 7 day share price return and a 3 year total shareholder return of...

Pelagos Insurance Capital (PLGO) opened 2026 with Q1 revenue of US$610.6 million and basic EPS of US$1.16. Trailing twelve month revenue was US$2.45 billion with EPS of US$3.70, framing a period where the company has moved from losses into consistent profitability over the past year. Over recent quarters, revenue has ranged between US$589.3 million and US$673.8 million, while quarterly EPS has shifted from a loss of US$1.09 in Q4 2024 to positive readings across 2025 and into 2026. This...

Earlier this month, Rollins, Inc. held an Analyst/Investor Day where, according to RBC Capital Markets, the company was expected to reaffirm its 2026 and medium-term outlook, emphasizing its pricing approach and operational efficiency. Meanwhile, Orkin Canada, a Rollins subsidiary, highlighted seasonal carpenter ant risks and shared practical prevention guidance, underscoring how pest trends can support demand for the group’s services. We’ll now examine how Rollins’ confidence in its...

Capital Southwest (CSWC) closed FY 2026 with fourth quarter revenue of US$57.8 million and basic EPS of US$0.48, set against trailing 12 month revenue of US$232.1 million and EPS of US$2.00. Over recent periods, the company has seen revenue range from US$52.4 million in FY 2025 Q4 to US$61.4 million in FY 2026 Q3, with quarterly EPS moving between US$0.33 and US$0.57 over the same span, while trailing net profit margin reached 48.7% and earnings growth over the past year was 61.7%. For...

Recent share performance and business mix Mueller Water Products (MWA) has been drawing investor attention after its stock rose 1.7% over the past day, even as returns over the past month and past 3 months declined 14.3% and 14.2% respectively. The company operates across two main segments: Water Flow Solutions and Water Management Solutions. It generates revenue of $1.46b and net income of $207.4m, with annual revenue growth of 3.3% and net income growth of 10.0%. See our latest analysis for...